Patents by Inventor Michael Hocker

Michael Hocker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MAGEA3 BINDING ANTIBODIES
    Publication number: 20140186363
    Abstract: The present invention relates to MAGEA3 binding antibodies.
    Type: Application
    Filed: May 23, 2012
    Publication date: July 3, 2014
    Applicants: UNIVERSITY OF ZURICH, CT ATLANTIC LTD.
    Inventors: Christoph Esslinger, Michael Höcker, Martin Treder, Alexander Knuth, Elke Jaeger
  • MAGEA3 BINDING ANTIBODIES
    Publication number: 20140093514
    Abstract: The present invention relates to MAGEA3 binding antibodies.
    Type: Application
    Filed: May 23, 2012
    Publication date: April 3, 2014
    Applicants: University of Zurich, CT ATLANTIC LTD.
    Inventors: Christoph Esslinger, Michael Höcker, Martin Treder, Alexander Knuth, Elke Jäger
  • Communications channel interposer, method and program product for verifying integrity of untrusted subsystem responses to a request
    Publication number: 20070162621
    Abstract: In a communications channel coupled to multiple duplicated subsystems, a method, interposer and program product are provided for verifying integrity of subsystem responses. Within the communications channel, a first checksum is calculated with receipt of a first response from a first subsystem responsive to a common request, and a second checksum is calculated for a second response of a second subsystem received responsive to the common request. The first checksum and the second checksum are compared, and if matching, only one of the first response and the second response is forwarded from the communications channel as the response to the common request, with the other of the first response and the second response being discarded by the communications channel.
    Type: Application
    Filed: October 27, 2005
    Publication date: July 12, 2007
    Applicant: International Business Machines Corporation
    Inventors: Vincenzo Condorelli, Thomas Dewkett, Michael Hocker, Tamas Visegrady
  • Urea derivatives as inhibitors for CCR-3 receptor
    Patent number: 6875884
    Abstract: Urea and thiourea derivatives inhibit cell function of the chemokine receptor CCR-3. These compounds offer an effective means for treating a range of diseases thought to be mediated by the CCR-3 receptor. A variety of useful urea and thiourea derivatives can be synthesized using liquid and solid phase synthesis protocols.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: April 5, 2005
    Assignee: Kirin Beer Kabushiki Kaisha
    Inventors: Janak Padia, Michael Hocker, Tsuyoshi Nishitoba, Hirohi Ohashi, Eiji Sawa